Litcius/Paper detail

Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma

Ye‐Lin Liang, Junyan Li, Qian Li, Ling‐Long Tang, Lei Chen, Yan‐Ping Mao, Qing‐Mei He, Xiaojing Yang, Yuan Lei, Xiaohong Hong, Yin Zhao, Shiwei He, Ying Guo, Yaqin Wang, Panpan Zhang, Na Liu, Ying‐Qin Li, Jun Ma

2020Theranostics30 citationsDOIOpen Access PDF

Abstract

The PSDM could be a useful liquid biopsy tool to effectively predict distant metastasis and the benefit of induction chemotherapy in patients with LA-NPC.

Topics & Concepts

Nasopharyngeal carcinomaMedicineOncologyInternal medicineDistant metastasisMetastasisChemotherapyRadiation therapyCancerHead and Neck Cancer StudiesSalivary Gland Tumors Diagnosis and TreatmentCancer-related gene regulation
Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma | Litcius